4 assets in Hurler Syndrome

Therapeutic assets addressing Hurler Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Thiotepa Hurler Syndrome	University of Florida	P2	BB (64)
Busulfanum Hurler Syndrome	Masonic Cancer Center, University of Minnesota	P2	B (57)
Cald Hr-D Hurler Syndrome	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Experimental: Otl-203 Hurler Syndrome	Orchard Therapeutics	P3	NR ()